The IL-1 Family and Its Role in Atherosclerosis
Open Access
- 20 December 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (1) , 17
Abstract
The IL-1 superfamily of cytokines is a central regulator of immunity and inflammation. The family is composed of 11 cytokines (with agonist, antagonist, and anti-inflammatory properties) and 10 receptors, all tightly regulated through decoy receptor, receptor antagonists, and signaling inhibitors. Inflammation not only is an important physiological response against infection and injury but also plays a central role in atherosclerosis development. Several clinical association studies along with experimental studies have implicated the IL-1 superfamily of cytokines and its receptors in the pathogenesis of cardiovascular disease. Here, we summarize the key features of the IL-1 family, its role in immunity and disease, and how it helps shape the development of atherosclerosis.Keywords
Funding Information
- Agencia Nacional de Investigación y Desarrollo (1210655, ICN2021_004, 21201346)
This publication has 222 references indexed in Scilit:
- Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculatureJournal of Molecular and Cellular Cardiology, 2013
- Interleukin 18 and coronary heart disease: Prospective study and systematic reviewAtherosclerosis, 2011
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasomeCell Death & Disease, 2011
- IL-37 is a fundamental inhibitor of innate immunityNature Immunology, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Inflammatory arthritis in caspase 1 gene–deficient mice: Contribution of proteinase 3 to caspase 1–independent production of bioactive interleukin‐1βArthritis & Rheumatism, 2009
- An Autoinflammatory Disease Due to Homozygous Deletion of theIL1RNLocusNew England Journal of Medicine, 2009
- Interleukin-18 and the risk of future cardiovascular disease among initially healthy womenAtherosclerosis, 2009
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- Inflammation in atherosclerosisNature, 2002